Deterrents to HIV-patient initiation of antiretroviral therapy in Urban Lusaka, Zambia: A qualitative study

AIDS Patient Care and STDs

Volumn 27, Issue 4, 2013, Pages 231-241

  Musheke, Maurice ^a,b,c   Bond, Virginia ^a,d   Merten, Sonja ^b,c  

^a UNIVERSITY OF ZAMBIA   (Zambia)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIVIRAL THERAPY; ARTICLE; AUDIO RECORDING; DRUG BIOAVAILABILITY; DRUG EFFICACY; FEMALE; HEALTH BELIEF; HEALTH CARE COST; HERBAL MEDICINE; HOME CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; QUALITATIVE RESEARCH; RESIDENTIAL AREA; SOCIAL INTERACTION; SPIRITUAL HEALING; TREATMENT REFUSAL; ZAMBIA;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; CULTURE; FEMALE; FOCUS GROUPS; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PERCEPTION; POVERTY AREAS; QUALITATIVE RESEARCH; SELF EFFICACY; SEVERITY OF ILLNESS INDEX; SOCIAL STIGMA; SOCIAL SUPPORT; TIME FACTORS; URBAN POPULATION; YOUNG ADULT; ZAMBIA;

EID: 84876126601     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2012.0341     Document Type: Article

References (56)

1. Joint United Nations Programme on AIDS. Global Report: UNAIDS Report on the Global AIDS Epidemic. Geneva, WHO, 2010.
2. Katz IT, Essien T, Marinda ET, et al. Antiretroviral therapy refusal among newly diagnosed HIV-infected adults. AIDS 2011;25:2177-2181.
3. Murphy RA, Sunpath H, Taha B, et al. Low uptake of antiretroviral therapy and high mortality after tuberculosis and opportunistic infection in Kwazulu-Natal, South Africa. Int J Tuberc Lung Dis 2010;14:903-908.
4. Maisels L, Steinberg J, Tobias C. An investigation of why eligible patients do not receive ART. AIDS Patient Care STDs 2001;15:185-191. (Pubitemid 32374224)
5. Beer L, Fagan JL, Valverde E, Bertolli J. Health-related beliefs and decisions about accessing HIV medical care among HIV-infected persons who are not receiving care. AIDS Patient Care STDs 2009;23:785-792.
6. Gold RS, Hinchy J, Batrouney CG. The reasons behind decisions not to take up antiretroviral therapy among in Australians infected with HIV. Int J STDs AIDS 2000;11:361-370. (Pubitemid 30352682)
7. Gold RS, Ridge DT. "I will start treatment when I think time is right": HIV positive gay men talk about their decision not to access antiretroviral therapy. AIDS Care 2001;13:693-708. (Pubitemid 34014236)
8. Alfonso V, Bermbach N, Geller J, Montaner JSG. Individual variability in barriers affecting people's decision to take HAART: A qualitative study identifying barriers to being on HAART. AIDS Patient Care STDs 2006;20: 848-857. (Pubitemid 46106072)
9. Gellaitry G, Cooper V, Davies C, et al. Patients' perception of information about HAART: Impact on treatment decisions. AIDS Care 2005;17:367-376. (Pubitemid 40188919)
10. Zachariah R, Harries AD, Manzi M, et al. Acceptance of antiretroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. PLoS One 2010;1:e121.
11. Garland PM, Valverde EE, Fagan J, et al. HIV counseling, testing and referral experiences of persons diagnosed with HIV who have never entered medical care. AIDS Educ Prev 2011;23:117-127.
12. Wringe A, Roura M, Urassa M, et al. Doubts, denial and divine intervention: Understanding delayed attendance and poor retention rates at a HIV treatment programme in rural Tanzania. AIDS Care 2009;21:632-637.
13. Central Statistics Office (CSO), Ministry of Health (MoH), Tropical Disease Research Centre (TDRC), University of Zambia, and Macro International Inc. Zambia Demographic and Health Survey, 2007. Calverton, Maryland, USA: CSO and Macro International Inc., 2009.
14. Ministry of Health. Adult and Adolescent Antiretroviral Therapy Protocols (2nd edition). Lusaka, MoH, 2010.
15. Ministry of Health. Zambia Country Report. Monitoring the Declaration of Commitment on HIV and AIDS and the Universal Access. Biennial Report, January 2010-December 2011. Submitted to the United Nations General Assembly Special Session on AIDS. Lusaka, NAC/MoH, March 2012.
16. Fox MP, Mazimba A, Seidenberg P, et al. Barriers to initiation of antiretroviral treatment in rural and urban Zambia: A cross-sectional study of cost, stigma and perception of treatment. J Int AIDS Soc 2010;13:8.
17. Murray LK, Semrau K, McCauley E, et al. Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: A qualitative study. AIDS Care 2009;21: 78-86.
18. Grant E, Logie D, Masura M, et al. Factors facilitating and challenging access and adherence to antiretroviral therapy in a township in the Zambian Copperbelt: A qualitative study. AIDS Care 2008; 20:1155-1160.
19. Simpson A. Boys to Men in the Shadow of AIDS: Masculinities and HIV risk in Zambia. Palgrave Macmillan, New York, 2009.
20. Roura M, Busza J, Wringe A, et al. Barriers to sustaining antiretroviral treatment in Kisesa, Tanzania: A follow up study to understand attrition from antiretroviral programme. AIDS Patient Care STDs 2009;23:203-210.
21. Musheke M, Bond M, Merten S. Individual and contextual factors influencing patient attrition from antiretroviral therapy care in an urban community of Lusaka, Zambia. J Int AIDS Soc 2012;15:17366.
22. Latkin CA, Knowlton AR. Micro-social structural approaches to HIV prevention: A social ecological perspective. AIDS Care 2005;17:S102-S113. (Pubitemid 40979481)
23. Skovdal M, Campbell C, Nyamukapa C, Gregson S. When masculinity interferes with women's treatment of HIV infection: A qualitative study about adherence to antiretroviral therapy in Zimbabwe. J Int AIDS Soc 2011;14:29.
24. Merten S, Kenter E, Mckenzie O, et al. Patient-reported barriers and drivers of adherence to antiretrovirals in sub-Saharan Africa: A meta-ethnography. Trop Med Int Health 2010;15:1-18.
25. Van Servellen G, Lombardi E. Supportive relationships and medication adherence to antiretroviral therapy in HIV-infected, low income Latinos. West J Nurs Res 2005;27:1023-1039. (Pubitemid 41719897)
26. Duff P, Kipp W, Wild TC, et al. Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a general hospital in Western Uganda. J Int AIDS Soc 2010;13:37.
27. Unge C, Johansson A, Zachariah R, et al. Reasons for unsatisfactory acceptance of antiretroviral treatment in the urban Kibera slum, Kenya. AIDS Care 2008;20:146-149. (Pubitemid 351651266)
28. Unge C, Ragnarsson A, Ekström AM, et al. The influence of traditional medicine and religion on discontinuation of ART in an urban informal settlement in Nairobi, Kenya. AIDS Care 2011;23:851-858.
29. Graneheim UH, Lundman B. Qualitative content analysis in nursing research: Concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today 2004;24:105-112. (Pubitemid 38232767)
30. Burnard P. A method of analysing interview transcripts in qualitative research. Nurse Educ Today 1991;11:461-466.
31. McKague M, Verhoef M. Understanding of health and its determinants among clients and providers at an urban community health centre. Qual Health Res 2003;13:703-717. (Pubitemid 44526612)
32. Siegel K, Gorey E. HIV-infected women: Barriers to AZT use. Soc Sci Med 1997;45:15-22. (Pubitemid 27268212)
33. Siegel K, Schrimshaw EW, Dean L. Symptom interpretation and medicine adherence among late middle age and older HIV infected adults. J Health Psychol 1999;4:247-257. (Pubitemid 29201964)
34. Lumme-Sandt K, Hervonen A, Jylha M. Interpretive repertoires of medicine among the oldest-old. Soc Sci Med 2000; 50:1843-1850.
35. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach. Geneva, WHO, 2010.
36. Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. Lancet 2009;373:48-57.
37. Wong WKT, Ussher J. How do subjectively constructed meanings ascribed to anti-HIV treatments affect treatmentadherent practice? Qual Health Res 2008,18:458-468. (Pubitemid 351420316)
38. Rier D, Indyk D. Flexible rigidity: Supporting HIV treatment adherence in a rapidly changing treatment environment. Soc Work Health Care 2006;42:133-150. (Pubitemid 44161877)
39. Skovdal M, Campbell C, Nhongo K, et al. Contextual and psychosocial influences on antiretroviral therapy adherence in rural Zimbabwe: towards a systematic framework for programme planners. Int J Health Plann Mgmt 2011;26:296-318.
40. Barton LM, Wilson IB, Bowser DM, Kerr SE. Taking antiretroviral therapy for HIV infection: Learning from patients' stories. J Gen Intern Med 2000;15:848-858. (Pubitemid 32011834)
41. Munro SA, Lewin SA, Smith HJ, et al. Patient adherence to tuberculosis treatment: A systematic review of qualitative findings. Plos Med 2007;4:e238.
42. Parker RG, Easton D, Klein CH. Structural barriers and facilitators in HIV prevention: A review of international research. AIDS 2000;14:S22-S32.
43. Sumartojo E. Structural factors in HIV prevention: Concepts, examples and implications for research. AIDS 2000;14:S3-S10.
44. Chileshe M, Bond VA. Barriers and outcomes: TB patients co-infected with HIV accessing antiretroviral therapy in rural Zambia. AIDS Care 2010;22:51-59.
45. Tuller DM, Bangsberg DR, Senkungu J, et al. Transport costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: A qualitative study. AIDS Behav 2010;14:778-784.
46. Hardon AP, Akurut D, Comoro C, et al. Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa. AIDS Care 2007;19:658-665. (Pubitemid 46763738)
47. National AIDS Council. Zambia Biennial Country Report 2008-2009: Monitoring the declaration of commitment on HIV and AIDS and the universal access. Submitted to the United Nations General Assembly Special Session on AIDS. Lusaka, NAC, March 2010.
48. IRIN Plus News (14th March 2010). Zambia: Corruption scandal rocks ARV programme. Available from: www.plusnews.org (last accessed May, 10, 2012).
49. The Post Newspaper (30th January 2012): Africa is too dependent for AIDS Response, says UNAIDS. Available from: http://www.postzambia.com (last accessed May, 18, 2012).
50. Berhanu Z. Holy water as an intervention for HIV/AIDS in Ethiopia. J HIV AIDS Soc Serv 2010;9:240-260.
51. Tocco JU. 'Every disease has its cure': Faith and HIV therapies in Islamic northern Nigeria. Afri J AIDS Res 2010;9:385-395.
52. Togarasei L. Christian theology of life, death and healing in an era of antiretroviral therapy: Reflections on the responses of some Botswana churches. Afri J AIDS Res 2010;9:429-435.
53. Balogun AS. Islamic perspectives on HIV/AIDS and antiretroviral treatment: The case of Nigeria. Afri J AIDS Res 2010;9:459-466.
54. Banda Y, Chapman V, Goldenberg RL, et al. Use of traditional medicine among pregnant women in Lusaka, Zambia. J Altern Complement Med 2007;13:123-127.
55. Morris K. Treating HIV in South Africa-A tale of two health systems. The Lancet 2001;1190.
56. World Health Organization: In vitro screening of traditional medicines for anti-HIV activity: Memorandum from a WHO meeting. Bull World Health Organ 1989;87:613-618.